BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer

Figure 2 Effects of BTNL9 expression on proliferation and metastasis of pancreatic cancer cells. A: Expression of BTNL9 in common pancreatic cancer (PC) cell lines; B: Establishment of stable PC cell model of BTNL9 overexpression; C: The effect of BTNL9 expression on cell proliferation assessed by CCK8 assay; D: The clone formation assays analyzed the effect of BTNL9 expression on cell clonogenesis; E: The EdU experiment showed a decrease in the proportion of EDU-positive cells by overexpressing BTNL9; F: Transwell experiment showed the migration and infiltration ability decreased when BTNL9 was overexpressed. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001.